Novo Nordisk

NYSE: NVO
Share price (5/17/24): $131.89
Market cap (5/17/24): $453 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

42 Novo Nordisk Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

ended 12/31/19 FY 2019

Prospectuses and Registrations Filter

Registration of ADRs

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer

Ownership Filter

Annual report of employee stock purchase, savings and similar

Annual report of employee stock purchase, savings and similar

Annual report of employee stock purchase, savings and similar

News Filter

a/S – Share Repurchase Programme

Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Once-Weekly and Once-Monthly Mim8 Demonstrate Superior Reduction of Treated Bleeding Episodes Compared to On-Demand and Prior Prophylaxis Treatment in People With Haemophilia a in the Frontier 2 Trial

Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Proxies

No filings in this category.

Other Filter

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC